BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in infectious and rare diseases. Founded in 1986, BioCryst has more than 100 employees and is experiencing continuous growth. The Company’s headquarters are located in Research Triangle Park, North Carolina and its Discovery Center of Excellence is in Birmingham, Alabama. With expertise in drug discovery, clinical development, regulatory affairs and product commercialization, BioCryst continues to advance clinical programs and generate new compounds from its own discovery engine. We are proud of our culture of engagement and accountability that rewards people for innovative thinking and achievement of key objectives. The commitment of BioCryst remains unchanged. We continue to be passionate about developing and marketing novel therapeutics for patients with rare and serious diseases.